About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Treatment Approach for MSI-H/dMMR CRC
Treatment Approach for MSI-H/dMMR CRC
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
C
Utilizing Single-Agent Immunotherapy in MSI-H CRC
By
Chiara Cremolini
4 Videos
160 views
March 14, 2022
0 Comments
Login to view comments.
Click here to Login
Treatment Approach for MSI-H/dMMR CRC
05:20
ecancer
ASCO 2021 Update on Pembrolizumab vs. Chemo in MSI-H/dMMR mCRC: Fina…
Feat.
T. André
30:44
LARVOL
ASCO 2021 Highlights on Advanced Gastrointestinal Cancers: 1L Nivo +…
Feat.
M. Salem,
M. Lewis,
K. Knopf
27:09
2021 Virtual ESMO Review
ESMO 2021 Upper GI Updates: Advanced ESCC and GEJ, HER2+ GC, CAR T, …
Feat.
S. Klempner
20:33
UChicago Medicine: Sixth Annual Updates in Digestive Diseases
Colon Cancer Screening and Surveillance in 2021
Feat.
N. Sengupta
16:08
UChicago Medicine: Sixth Annual Updates in Digestive Diseases
Updates in Genetic Testing for Familial Cancers
Feat.
C. Drogan
07:51
University of Colorado Cancer Center
Updates in dMMR/MSI CRC: Overview of Recent Immunotherapy Advances
Feat.
W. Messersmith
18:08
10th Annual Winship Cancer Institute Gastrointestinal Cancer Virtual Symposium
Updates in Management of mCRC in Era of Comprehensive Genomic Analys…
Feat.
C. Wu
44:02
Total Health
Expert Discussion on mCRC: Pembro vs. Chemo for MSI-H dMMR Disease, …
Feat.
S. Jain,
M. Cho,
C. Eng,
A. Loaiza-Bonilla,
A. Parikh
09:44
ASCO GI 2022 Conference Coverage
ASCO GI 2022 Highlights: Clinical Utility of MSI-H Identified on Liq…
Feat.
P. Kasi
14:06
ASCO GI 2022 Conference Coverage
ASCO GI 2022 on the Emerging Roles of ctDNA as a Tool in Metastatic …
Feat.
A. Dasari
34:34
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
Immunology & IO in Lynch Syndrome: Immune System, MSI & Here…
Feat.
M. J. Hall
20:38
Nilofer Saba Azad
Emerging Approaches for Immunotherapy in CRC
20:26
Collaborative Group of the Americas for Inherited Gastrointestinal Cancers
Incidental Findings From Somatic Testing and Implications for Heredi…
Feat.
Z. Stadler
10:48
Daniel Ahn
Chemo & IO in MSI-H mCRC: What the Oncologist Should Know
24:51
UNC Lineberger Comprehensive Cancer Center
Updates in Treatment Sequencing by Molecular Profile in CRC and Bili…
Feat.
H. K. Sanoff
13:15
Penn Medicine Abramson Cancer Center
Colorectal Liver Metastases: Liver-Directed Therapies - Embolization…
Feat.
M. Soulen
15:26
Chiara Cremolini
Utilizing Single-Agent Immunotherapy in MSI-H CRC
19:03
2022 West Oncology Conference
Therapeutic Advances in CRC: The Real Deal or Just Hype?
Feat.
V. Morris
11:02
Cleveland Clinic Taussig Cancer Institute
Prognostic and Predictive Value of Microsatellite Instability Status…
Feat.
F. Baidoun
04:11
ASCO 2022 Conference Coverage
ASCO 2022 on CRC Metastatic dMMR Immuno-Therapy (COMMIT) Phase 3 Stu…
Feat.
M. Overman
43
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on CRC Metastatic dMMR Immuno-Therapy (C…
Feat.
M. Overman
08:41
ASCO 2022 Conference Coverage
ASCO 2022 on KEYNOTE-651: Pembrolizumab + mFOLFOX7/FOLFIRI for mCRC:…
Feat.
R. Kim
01:02
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on Pembrolizumab + mFOLFOX7/FOLFIRI for …
Feat.
R. Kim
